Skip to content

Effectiveness and evaluation of application of traditional Chinese medicine dressing therapy combined with utility model patent in clinical practice of peripheral phlebitis

Effectiveness and evaluation of application of traditional Chinese medicine dressing therapy combined with utility model patent in clinical practice of peripheral phlebitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000336
Enrollment
Unknown
Registered
2025-02-18
Start date
2024-09-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral phlebitis

Interventions

Observation Group :In the control group drug education, psychological care on the basis of compliance with medical advice to take traditional Chinese medicine dressing
control subjects :Peripheral phlebitis implementation of routine care drug education care of peripheral phlebitis follow the doctor's orders to give magnesium sulfat

Sponsors

Shanghai East Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1: The Western medical diagnosis is in accordance with the diagnostic criteria for phlebitis of the American Society for Intravenous Fluid Nursing 2: The Chinese medicine diagnosis conforms to the diagnostic criteria of Damp-Heat Stasis of Qingshedu in the Fifth Edition of Traditional Chinese Medicine Surgery for the New Century 3: Infusion of medications leading to phlebitis 4: The patient was over 18 years old 5: No immune system diseases and serious organ diseases 6: Voluntary acceptance of Chinese medicine treatment and the ability to return on time and complete clinical treatment observation as required

Exclusion criteria

Exclusion criteria: 1: Phlebitis from other causes (e.g. central venous cannulation via peripheral vein puncture) 2: Severe uncontrolled organic pathology or infection such as decompensated cardiac pulmonary hepatic or renal failure which precludes the application of herbal treatment 3: Patients who are not able to follow the study methods or do not comply with medical advice

Design outcomes

Primary

MeasureTime frame
Phlebitis Grading ;Blood count + crp ;NRS;GCQ;SAS;GAS;

Secondary

MeasureTime frame
recognition rate;TCM symptoms ;

Countries

China

Contacts

Public ContactXubowen

Shanghai East Hospital

terry918@sina.com021-38804518

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026